Clinical trial
Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery…
NCT00482287 · Meditor Pharmaceuticals Ltd., Industry · Withdrawn
Key facts
| NCT number | NCT00482287 |
|---|---|
| Title | Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients |
| Official title | A Phase II, Randomized, Double Blind, Placebo-controlled, Dose-escalating Study to Assess the Pharmacokinetics and Pharmacodynamics of MTR105 in Cardiac Surgery Induced Hypotension Patients During Weaning Off Cardiopulmonary Bypass |
| Lead sponsor | Meditor Pharmaceuticals Ltd., Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypotension, Cardiopulmonary Bypass |
| Intervention type | Drug |
| Interventions | MTR105 |
| Enrollment | 0 |
| Start date | Jan 1, 2008 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jun 5, 2007 |
| Last update posted | Apr 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: